Skip to main content

Ovarian Cancer Clinical Trials

Review the ovarian cancer clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 276-300 of 327

Indocyanine Green for Imaging of Solid Tumors during Surgery Compared to Standard of Care
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
Status: Active
Location: Montefiore Medical Center-Weiler Hospital, Bronx, New York
Fluorine F 18 Fluorthanatrace PET/CT for Imaging of Patients with Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
New PET Scan (68Ga-FAPI-46) for People with Cancers
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Transvaginal Ultrasound and Photoacoustic Imaging for the Imaging of the Ovary in Patients Who Are at High Risk for Ovarian Cancer
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
Hyperpolarized Carbon C13 Pyruvate with Magnetic Resonance Spectroscopy for the Detection of Ovarian Cancer and Assessment of Aggressiveness
Status: Temporarily Closed to Accrual
Location: M D Anderson Cancer Center, Houston, Texas
Fluorine F 18 Fluorthanatrace Biodistribution, Metabolism and Excretion Analysis in Patients with Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status: Temporarily Closed to Accrual
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Genetic Education for BRCA Families
Status: Active
Location: 5 locations
An Electronic Decision Aid Compared to Traditional Genetic Counseling for Genetic Testing Decision-Making in Ovarian or Pancreatic Cancer
Status: Active
Location: 4 locations
A Digital Health Tool for Improving Knowledge and Uptake of Genetic Testing among Black Cancer Survivors
Status: Active
Location: 2 locations
Access to Genetic Testing in Underserved Patients with Cancer
Status: Active
Location: 2 locations
A Collaborative Agenda-Setting Intervention (CASI) for the Improvement of Communication and Health-Related Quality of Life in Advanced or Recurrent Ovarian Cancer Patients
Status: Active
Location: 2 locations
A Support Program (BOLSTER) for the Improvement of Quality of Life in Metastatic Gynecologic or Gastrointestinal Cancer Patients with Complex Care Needs and their Caregivers, BOLSTER Trial
Status: Active
Location: 2 locations
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Status: Active
Location: Mayo Clinic in Florida, Jacksonville, Florida
Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Question Prompt List Communication Intervention for Improving Self-Efficacy and Communication Outcomes in Patients with Gynecological Cancer, ASQ-GYO Trial
Status: Active
Location: Wayne State University/Karmanos Cancer Institute, Detroit, Michigan
Developing and Testing a Low Literacy Spanish Language Shared Decision-Making Tool for Advanced Ovarian Cancer Maintenance Therapy
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients with Cancer
Status: Active
Location: Virginia K Crosson Cancer Center, Fullerton, California
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Status: Active
Location: 2 locations
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Status: Active
Location: See ClinicalTrials.gov
Collecting Blood Samples from Patients with and without Cancer to Evaluate Tests for Early Cancer Detection
Status: Active
Location: 722 locations
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Status: Active
Location: 21 locations
Universal Genetic Testing for Cancer Risk Reduction: A Prospective Interventional Pilot Study
Status: Active
Location: Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York